Reporting directly to the Director of Marketing for Seres-109, you will be responsible for developing and aligning the execution of HCP and/or DTC branded marketing strategy and tactics in preparation for the launch of SER-109 in recurrent C.
Dificile infection (rCDI).
What You’ll Do
In collaboration with colleagues at Seres Therapeutics:
• Ensure robust and ownable positioning and branding to differentiate SER-109 in the future rCDI market
• Development of the launch branded campaign, including messaging and effective promotional resources across communication channels to enhance customer engagement
• Lead and foster collaboration with other team members (marketing, sales, analytics, market access, medical affairs, etc.) to develop and execute programs and materials to support best-in-class launch of SER-109 in rCDI
• Lead and implement various aspects of conference presence and initiatives
• Develop strong relationships with key opinion leaders and HCP customers
• Identify value-maximizing and efficient go to market model for the launch
• Development and execution of branded patient messaging strategy, creative execution that grows patient awareness of branded product
• Engage in and interpret ongoing market research projects to validate brand positioning and promotional strategy
• Ensure compliance with corporate policies and procedures, as well as US healthcare laws and regulations
What You’ll Bring
• Minimum of a bachelor’s degree; advanced degree preferred
• 5+ years of broad experience in commercial roles with demonstrated progression in marketing; experience in sales or access desirable
• Experience in campaign development and multichannel planning/execution
• Ability to effectively manage a co-commercialization alliance
• US launch experience
• Demonstrated project leadership experience
• Resourceful, flexible, adaptable, diplomatic, and able to effectively deal with ambiguity
• Strong attention to detail
• Experience using innovative digital channels and platforms for communications.
• Fit with Aimmune culture and values, especially encouraging candidates with diverse backgrounds and those who are inclined to listen as much as they are to decide/lead.
Aimmune is a highly collaborative environment and, therefore, consensus building will be a critical skill to ensure success in this role
• Demonstrated ability to resolve conflict in a constructive manner
• Ability to seek diverse input from multiple constituents and stakeholders to drive decisions and innovative solutions
About Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies and food digestion & absorption.
Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to treat other food allergies.
In the area of food digestion and absorption, we offer treatments for Exocrine Pancreatic Insufficiency (EPI), a disorder where the pancreas does not make enough enzymes due to cystic fibrosis or other conditions